Jext (Epinephrine)

Epinephrine works by binding to and activating alpha‑1, alpha‑2, beta‑1 and beta‑2 adrenergic receptors throughout the body. Alpha‑1 activation causes vasoconstriction, raising systemic vascular resistance and blood pressure. Beta‑1 stimulation increases heart rate and contractility, boosting cardiac output. Beta‑2 activation relaxes bronchial smooth muscle, producing bronchodilation and suppressing mast‑cell mediator release, which together counteract the life‑threatening effects of anaphylaxis and severe bronchospasm.

The specific dose of Jext is determined by the prescribing clinician based on the patient’s age, weight, severity of the reaction, and local treatment guidelines. Typically, a single 0.3 mg intramuscular injection is administered for adults, with lower doses for children, but the exact amount and any repeat dosing must be directed by a qualified health professional.

The safety of epinephrine during pregnancy and lactation has not been definitively established, and it is classified as a pregnancy category unknown. Because the benefits of treating anaphylaxis or severe bronchospasm generally outweigh potential risks, epinephrine may be used when clearly needed, but clinicians should assess each case individually and consider fetal and neonatal safety.

To place an order, submit an enquiry on the Jext product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details—including cold‑chain handling where required—and assists with any necessary import documentation.

Jext contains the same active ingredient as other emergency epinephrine injectors such as EpiPen, but it is supplied as a standard injectable solution rather than a pre‑filled auto‑injector. This format may be preferred in clinical settings where dose flexibility or use with existing syringes is desired. Both deliver equivalent pharmacologic effects when administered correctly.

Jext must be stored refrigerated at 2 °C to 8 °C, protected from light, and must never be frozen or shaken. The product should be kept in its original packaging until use, and any vial that appears discolored or contains particles should be discarded. Proper cold‑chain management is essential to maintain potency.

Jext is administered by intramuscular injection, typically into the anterolateral thigh. The healthcare professional draws the prescribed volume into a sterile syringe, selects an appropriate needle length, and injects the solution swiftly. Immediate monitoring of the patient’s airway, breathing, and circulation is required after administration.

The most critical adverse events include severe hypertension, life‑threatening arrhythmias, and pulmonary edema, which can develop rapidly after injection. Patients should be observed for sudden spikes in blood pressure, irregular heart rhythms, chest pain, or difficulty breathing, and emergency medical support should be available to manage these complications.

Jext is contraindicated in individuals with known hypersensitivity to epinephrine or any component of the formulation. Caution is advised for patients with uncontrolled hypertension, certain cardiac disorders such as severe coronary artery disease, or those taking non‑selective beta‑blockers, as the drug may exacerbate these conditions. Clinical judgment is required to determine suitability.